UK MHRA renews GMP compliance of Kopran Ltd's two plants

Medicines & Healthcare products Regulatory Agency of United Kingdom (MHRA - UK) has renewed GMP Compliance Certificate for Company's two plant at it's manufacturing site at Khopoli, District-Raigad, Maharashtra that it complies with the Principles and guidelines of Good Manufacturing practices laid down in Regulation B17 of the Human Medicines Regulations 2012 (as amended).

This development illustrates the company's commitment to work closely with the MHRA-UK and strive for 100% cGMP Compliance at its manufacturing facilities.

Shares of Kopran Limited was last trading in BSE at Rs. 235.90 as compared to the previous close of Rs. 238.45. The total number of shares traded during the day was 53793 in over 1629 trades.

The stock hit an intraday high of Rs. 241.60 and intraday low of 234.05. The net turnover during the day was Rs. 12762390.00.

Source : Equity Bulls

Keywords

Kopran INE082A01010 UKMHRA GMPCompliance Renewal Khopoli Plants